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Abstract  21 
As it has been 30 years since a new anthelmintic class was released, it is appropriate  22 
to review management practices aimed at slowing the development of anthelmintic  23 
resistance to all drug classes. Recommendations to delay anthelmintic resistance and  24 
provide “refugia” are reviewed and a simulation model used to find optimum  25 
treatment strategies that maintain nematode control. Simulated Australian conditions  26 
indicated that a common successful low-risk treatment program was a rapid rotation  27 
between a “triple-combination” product (benzimidazole + levamisole + abamectin)  28 
and a new high-efficacy drug (monepantel). Where Haemonchus contortus was a  29 
threat, moxidectin was required at critical times because of its persistent activity  30 
against this parasite. Leaving up to 4% of adult sheep untreated provided sufficient  31 
“refugia” for non-selected worms to reduce the risk of selecting for anthelmintic  32 
resistance without compromising nematode control.   33 
For a new anthelmintic, efficacy estimated by faecal egg count reduction (FECR) is  34 
likely to be at or close to 100%, however using current methods the 95% confidence  35 
limits (CL) for 100% are incorrectly determined as 100%. The fewer eggs counted  36 
pre-treatment, the more likely an estimate of 100% will occur, particularly if the true  37 
efficacy is >90%. A novel way to determine the lower-CL (LCL) for 100% efficacy is  38 
to reframe FECR as a binomial proportion, i.e. define: n and x as the total number of  39 
eggs counted (rather than eggs per gram of faeces) for all pre-treatment and post- 40 
treatment animals, respectively; p the proportion of resistant eggs is p=x/n and  41 
percent efficacy is 100*(1-p) (assuming equal treatment group sizes and detection  42 
levels, pre- and post-treatment). The LCL is approximated from the cumulative  43 
inverse beta distribution by: 95%LCL=100*(1-(BETAINV(0.975,x+1,n-x+1))). This  44 
method is simpler than the current method, independent of the number of animals  45 Page 3 of 47
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tested, and demonstrates that for 100% efficacy at least 37 eggs (not eggs per gram)  46 
need to be counted pre-treatment before the LCL can exceed 90%. When nematode  47 
aggregation is high, this method can be usefully applied to efficacy estimates lower  48 
than 100%, and in this case the 95% upper-CL (UCL) can be estimated by:  49 
95%UCL=100*(1-(BETAINV(0.025,x+1,n-x+1))), with the LCL approximated as  50 
described above. A simulation study to estimate the precision and accuracy of this  51 
method found that the more conservative 99%CL was optimum; in this case 0.975 and  52 
0.025 are replaced by 0.995 and 0.005 to estimate the LCL and UCL, respectively.  53 
  54 
Keywords: Monepantel; Drug resistance; Refugia; Faecal egg count reduction test;  55 
Anthelmintic efficacy; Confidence limits; Precision accuracy.  56 
  57 
1. Introduction  58 
Broad-spectrum anthelmintics play a major role in the control of nematodes to  59 
improve animal health and production, and inevitably this has led to the development  60 
of anthelmintic resistance (Besier and Love, 2003; Kaplan, 2004; Jabbar et al., 2006).  61 
With the release of a new anthelmintic class (Kaminsky et al., 2008) it is appropriate  62 
to review what has been advocated to delay selection for drug resistance, and explore  63 
at methods for detecting resistance to indicate whether improvements can be made.  64 
  65 
Simulations by Dobson et al. (2011 a, b) to explore how a new anthelmintic could be  66 
best integrated with currently available drugs to delay drug resistance to all drug  67 
classes while maintaining effective nematode control in Australian sheep farming  68 
systems are also reviewed. Finally, problems associated with estimating confidence  69 
limits (CL) for the faecal egg count reduction test (FECRT) when apparent drug  70 Page 4 of 47
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efficacy is high, nematode aggregation is high, or few animals are available to test (as  71 
may be the case with horses) were examined. To estimate CL for a FECRT when  72 
efficacy was 100%, a different approach from conventional statistical methods was  73 
required. This involves a paradigm shift by determining the reliability of an assay  74 
from the total number of eggs counted pre-treatment rather than the currently used  75 
variables such as the eggs per gram in faeces (epg), group size and variance. The  76 
question: “Can this novel approach be more generally applied?” was explored.  77 
  78 
1.1 Anthelmintic rotations/alternations or combinations  79 
A review of the literature indicates that few publications have recommended that  80 
stockowners use a single anthelmintic in a control program for as long as it remains  81 
effective and then change to an alternate drug class. Le Jambre, Southcott and Dash  82 
(1977, 1978) initially advocated this approach, but Dash (1986) and Le Jambre (in  83 
Dobson et al., 2001) later advocated other strategies to delay resistance.  84 
  85 
The problem with the ‘use until resistance occurs’ approach is that once resistance to  86 
an anthelmintic is detected the resistance (R-) allele frequency is fixed in the  87 
nematode population at a relatively high level and co-adapted with other fitness traits  88 
(Smith, 1998). As a result the possibility of reintroducing the ‘used’ anthelmintic is  89 
generally eliminated. To delay selection for anthelmintic resistance (recommendations  90 
summarised in Table 1) the majority of modelling and research studies have  91 
concluded that unrelated anthelmintics be alternated annually or used as  92 
combinations, or that farm-specific advice is obtained regarding drugs and animal  93 
classes. In nematode and other pest species, combination therapy is generally seen as  94 
the best option to delay pesticide resistance (Table 1), although the combination  95 Page 5 of 47
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principle is not universally accepted. Because anthelmintics have different  96 
characteristics in terms of potency and persistence the most appropriate approach may  97 
be to match an anthelmintic to the particular time and circumstance rather than to  98 
advocate only one of the options in Table 1.  99 
  100 
1.2 Other methods to delay anthelmintic resistance  101 
Equally important to considering a drug rotation strategy is the management of  102 
animals and the timing of anthelmintic treatment. The development of anthelmintic  103 
resistance can be substantially delayed by implementing an appropriate treatment  104 
regimen (Gettinby et al., 1989; Barnes et al., 1990; Dobson et al., 1996). These  105 
authors showed that the use of ‘safe’ pastures for young stock can sufficiently reduce  106 
the number of anthelmintic treatments to slow selection for resistance. One risk  107 
associated with this strategy is that if sheep are treated and moved to pasture carrying  108 
no worm larvae (low ‘refugia’), rapid selection for resistance can occur.   109 
  110 
The importance of considering ‘refugia’ to avoid anthelmintic resistance was  111 
highlighted by van Wyk (2001): ‘refugium’ is the proportion of a parasite population  112 
that escapes treatment, but successfully establishes in a host at a later stage and  113 
produces viable off-spring. This strategy generally aims at the selective treatment of  114 
animals at risk, and the principle has been demonstrated in practice by a number of  115 
researchers. Hoste et al. (2002) was able to maintain nematode control in alpine dairy  116 
goats in France by treating only animals that were either high milk producers or in  117 
their first lactation. Similarly, haemonchosis was successfully controlled by treating  118 
only animals exhibiting clinical signs of anaemia
 (van Wyk et al., 2002). On four  119 
farms in southern Italy, Cringoli et al. (2009) left 40-60% of dairy sheep untreated  120 Page 6 of 47
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without jeopardising the control of mixed infections of mainly Trichostrongylus,  121 
Haemonchus and/or Nematodirus. Leathwick et al. (2006a, b) and Waghorn et al.  122 
(2008) explored the possibility of leaving some sheep untreated to create refugia and  123 
discussed the difficulties of slowing selection for resistance without creating levels of  124 
parasitism that would reduce production. Earlier, Leathwick et al. (1995)  125 
demonstrated that treating ewes prior to any lamb anthelmintic treatment program will  126 
greatly increase selection for anthelmintic resistance. A survey of anthelmintic use in  127 
New Zealand found practices that aim to provide a refugia of susceptible worms and  128 
that minimise the risk of introduction of resistance through effective quarantine  129 
drenching were indeed associated with low levels of ML resistance (Lawrence et al.,  130 
2006). More recently, in studies in Western Australia, Besier et al. (2010) found that  131 
using a body condition score treatment index, 50% or more of Merino sheep could be  132 
left untreated when a flock treatment was given, without a significant reduction in  133 
flock productivity.   134 
  135 
2. Simulations of control options in Australia with a new anthelmintic  136 
To assess how best to delay selection for resistance to a new anthelmintic and  137 
maintain the effectiveness of current anthelmintics, Dobson et al. (2011 a, b) modelled  138 
treatment options for self-replacing Merino flocks in four different climates. A  139 
simulation model to predict gastro-intestinal nematode populations and the evolution  140 
of drug resistance to help identify low- and high-risk treatment programs was used.  141 
Simulations were defined by anthelmintic treatment, lambing dates, sheep movements  142 
between paddocks and historical weather data. Kojonup (Western Australia, Western  143 
Australia, (WA)) and Hamilton (Victoria, Victoria (VIC)) represented winter rainfall  144 
zones, with hotter and drier summers in WA.  Glen Innes and Armidale (both northern  145 Page 7 of 47
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New South Wales (NSW) are summer rainfall zones selected for years with medium  146 
and high risks for haemonchosis, respectively. In the simulations three anthelmintics;  147 
monepantel (MPL), moxidectin (MOX) and a ‘triple combination’ (COM) of  148 
benzimidazole (BZ) + levamisole (LEV) + abamectin (ABA), were used under a  149 
variety of combination and rotation programs. A risk-based scoring system was used  150 
to rank relative effectiveness of the treatment options on their ability to control  151 
nematode populations (productivity) and delay selection for resistance to all drug  152 
classes in each worm genus (Trichostrongylus at all sites, Haemonchus in NSW and  153 
Teladorsagia in WA and VIC). The application of MPL plus COM (i.e. four active  154 
ingredients) for all anthelmintic treatments most effectively delayed selection for  155 
anthelmintic resistance but was not always optimal for nematode control. Because of  156 
cost constraints or the reluctance of graziers to apply multiple applications, Table 2  157 
illustrates other low-risk programs for the three regions, which can be summarised as  158 
a rapid rotation between a triple combination product and the new drug (MPL). In  159 
NSW, where Haemonchus was a major threat, it was necessary to include MOX at  160 
critical times in the drug rotation because of its persistent activity against  161 
Haemonchus. Additional grazing management planning may also overcome this  162 
problem but this was not explored. At the high-risk site for Haemonchus, the schedule  163 
in Table 2 was insufficient to prevent unacceptable host mortalities, but these were  164 
prevented by rotation at each treatment between MOX and MPL (option NSWr). In  165 
this, it was assumed the efficacy of MOX against homozygote susceptible (SS),  166 
heterozygotes (RS) and homozygote resistant (RR) genotype Haemonchus adults were  167 
99.9%, 99.9% and 87.3%, respectively. Persistent activity against incoming  168 
Haemonchus infective larvae was assumed to last for 32 days and was 95%, 55% and  169 
55% against SS, RS and RR genotypes. From these assumptions it follows that MOX  170 Page 8 of 47
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efficacy remained relatively high (> 85%) even when ML-resistance was high and  171 
some but not all ML-resistant incoming larvae were prevented from establishing in  172 
the host. Consequently MOX became, in effect, a short-acting drug with moderate  173 
efficacy when ML-resistance was high.  174 
  175 
The triple combination played a useful role in delaying anthelmintic resistance despite  176 
setting resistance to the component active ingredients at relatively high levels. The  177 
initial R-allele frequency was set at 40% for both BZ and LEV, i.e. resistance was  178 
assumed to be common. Initial ML R-allele frequency was set at 3% denoting an  179 
emerging resistance problem, selected for by the drugs ABA and MOX. The R-allele  180 
frequency was set at <0.005% for the new class of drugs (amino-acetonitrile  181 
derivatives, represented by MPL) and was purposely set such that resistance would  182 
emerge in less than 10 years if MPL was used for all treatments, and R-allele  183 
frequency therefore varied slightly between nematode species.  184 
  185 
In addition to the regimens shown in Table 2, Dobson et al. (2011a) explored the  186 
importance of nematode populations in refugia at all sites by leaving 0, 1, 4, 7 or 10%  187 
of adult sheep untreated. They concluded that leaving up to 4% of adult sheep  188 
untreated reduced the risk of selecting for anthelmintic resistance without  189 
compromising nematode control. Similar findings were made by Pech et al. (2009)  190 
who modelled the optimal economic management of anthelmintic resistance in sheep  191 
flocks exposed to Teladorsagia under WA conditions with refugia managed by  192 
leaving 0, 2, 5 or 10% of sheep untreated. These authors concluded that anthelmintic  193 
resistance greatly reduced the profit of sheep enterprises and leaving 2% of the flock  194 
untreated optimised profit by allowing the effectiveness of drenches to be prolonged,  195 Page 9 of 47
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providing the best long term benefit. The concept of deliberately leaving some sheep  196 
untreated is potentially controversial and farmers may have difficulty in accepting it  197 
(discussed by Waghorn et al., 2008). However, as it has been approximately 30 years  198 
since the last new anthelmintic class was commercialised, with the release of MPL it  199 
is important to promote management practices that will slow the development of  200 
anthelmintic resistance to all drug classes.  201 
  202 
3. Detecting anthelmintic resistance and estimating drug efficacy by FECRT  203 
Only one test is currently widely available for field use for estimating drug efficacy,  204 
the faecal worm egg count reduction test (FECRT). Debate has occurred over whether  205 
arithmetic (AM) or geometric (GM) means are most appropriate for determining drug  206 
efficacy (Dash et al., 1988; Vercruysse et al., 2010). Dobson et al. (2009)  207 
demonstrated (by Monte Carlo simulation techniques, used when analytical solutions  208 
are intractable) that AMs provide the best estimate of efficacy and clearly  209 
demonstrated that GMs often yield extremely biased results. Recently, research has  210 
addressed how better to analyse data from a FECRT using Monte Carlo or bootstrap  211 
techniques, particularly in relatively difficult situations involving low egg count data  212 
such as can occur with horses and cattle (Cabaret et al., 2004; Vidyashankar et al.,  213 
2007; Denwood et al., 2010). The problem with these approaches is that they are  214 
computationally intensive and require a high level of mathematical sophistication,  215 
which is available to researchers but generally not to veterinary consultants who  216 
conduct FECRTs.  217 
  218 
In a review of published anthelmintic efficacy data, McKenna (2006) compared  219 
efficacy based on controlled slaughter trials, which are the ‘gold standard’, with four  220 Page 10 of 47
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methods for calculating efficacy from FECRT. McKenna (2006) found 61 data sets  221 
with both worm count and FECRT data and from these he estimated sensitivity (Se):  222 
the proportion of anthelmintic resistance cases correctly diagnosed as ‘resistant’ by  223 
the FECRT methods, and specificity (Sp): the proportion of susceptible nematode  224 
isolates correctly diagnosed as ‘susceptible’ by the FECRT methods. The four FECRT  225 
percent efficacy estimates were defined by McKenna (2006) as:  226 
FECRT1 = 100 x (1–[T2/T1] x [C1/C2]);   227 
FECRT2 = 100 x (1–[T2/C2]);  228 
FECRT3 = 100 x (1–[T2/T1]);  229 
FECRT4 = 100 x (1–[T2/C1]);  230 
where T1 and T2 represented the mean pre- and post-treatment faecal nematode egg  231 
counts of a treated group, and C1 and C2 represented the mean pre- and post- 232 
treatment counts of an untreated control group, respectively.  233 
  234 
For all estimation methods Sp was 1, i.e. 100% or no false positives (i.e. 1-Sp) while  235 
the false negative rate (1-Se) ranged from 8% (for FECRT1-2) to 4% (for FECRT3- 236 
4). Because there was no significant difference between the four estimates of Se (0.92  237 
vs. 0.96), McKenna (2006) concluded that it was simplest to use either FECRT2 or  238 
FECRT4 as these required the minimal cost or labour. However, McKenna (2006)  239 
was concerned with sheep, where the data is generally less constrained by low egg  240 
counts and group sizes are determined by cost considerations. For horses, common  241 
practice to estimate efficacy using pre- and post-treatment counts from the same  242 
animals (FECRT3) (Denwood et al., 2010), in particular because of estimation  243 
problems associated with relatively low counts, high variability and small group sizes.   244 
  245 Page 11 of 47
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However, for the McKenna (2006) results it is important to note that using the post- 246 
treatment control group or correcting efficacy to account for changes in control group  247 
(Presidente, 1985) between the pre- and post-treatment counts (FECRT 1and 2)  248 
caused 4% more cases to be incorrectly diagnosed as susceptible, noting all estimates  249 
were based on the same data. This implies that the egg counts measured at the time of  250 
treatment (C1 or T1) are the most appropriate for estimating efficacy and the  251 
correction method of Presidente (1985) does not improve efficacy estimation. The  252 
correction is based on the assumption that parallel changes in egg counts occur in the  253 
treated group similar to those observed in the control group, however, this assumption  254 
is rarely justified and does not stand up to scrutiny, as demonstrated by McKenna  255 
(2006). In cattle, density-dependent control of fecundity, particularly for Ostertagia  256 
ostertagi (Smith et al., 1987), may well further exacerbate this problem. For example,  257 
counts of untreated control animals may decline because of density-dependent  258 
constraints on fecundity exacerbated by any incoming infection between pre- and  259 
post-treatment counts, while in treated groups the worms surviving treatment may  260 
have increased fecundity because of reduced worm populations or competition. In this  261 
situation correcting for changes in control egg count (as epg) or relying on post- 262 
treatment control egg count (FECRT1 or 2) will cause efficacy to be underestimated.  263 
  264 
The four methods for estimating efficacy (FECRT 1- 4) are dependent on determining  265 
a minimum of two mean egg counts and the variance of the means are components in  266 
the CL calculations:  267 
  95% lower CL=100*(1-(T2/C2)exp(+2.048√V)), where V = variance of  268 
reduction on log scale, which is a function of variance of the control and treated group  269 
mean egg count (for details, see Anderson et al., 1991; Coles et al., 1992). This is the  270 Page 12 of 47
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simplest form for estimating CL and can be used for FECRT 2 - 4. Lyndal-Murphy et  271 
al. (2010) provide a more complete expansion of this formula for estimating efficacy  272 
CL when corrections for changes in control counts are involved (i.e. FECRT 1).  273 
  274 
4. A novel way to estimate confidence limits for FECRT  275 
The FECRT essentially relies on the ratio of two means. However, to accurately  276 
estimate the mean egg count when the variance is high, a large number of animals is  277 
required (Morgan et al., 2005). Rather that attempting to estimate the mean it can be  278 
demonstrated (Section 4.5) that effort would be better directed to counting a large  279 
number of eggs pre-treatment from high shedding animals (e.g. the four animals in the  280 
group with the highest counts) and then counting the same animals with the same  281 
degree of sensitivity post-treatment, thus avoiding the low or zero egg producing  282 
animals. These animals contribute greatly to the variance but provide little useful  283 
information to the estimate of efficacy, and need be included only if the flock mean is  284 
to be estimated (e.g. with regard to pasture contamination). The required paradigm  285 
shift is to ignore the animal as the experimental unit, regarding the egg as the unit of  286 
interest. This can be defined as either susceptible or resistant, thus creating a binomial  287 
variable; the host thus becomes a vessel for supply of nematode eggs, which is the  288 
case for in vitro assays. The animal can be thought of as an in vivo equivalent of an in  289 
vitro culture system used to support the growth of micro-organisms for similar in vitro  290 
drug assays and replicate animals are equivalent to replicate assays. The advantage is  291 
that binomial CLs are defined for a single animal, based on how many eggs were  292 
counted, which provides an estimate of reliability for the assay (i.e. how accurately  293 
the drug efficacy was determined in one animal). When multiple animals are tested  294 
then the drug efficacy for the group or farm can be estimated. This focuses attention  295 Page 13 of 47
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on how many eggs are observed, rather than the number of animals in each group or  296 
the egg detection level.  297 
  298 
4.1 When the efficacy estimate is 100%  299 
The World Association for the Advancement of Veterinary Parasitology (WAAVP)  300 
guidelines for estimating efficacy by FECRT (Coles et al., 1992) provide  301 
straightforward methods for estimating the 95% CL that can be easily applied to  302 
routine field data. While these estimates are robust, a problem with the CL method  303 
occurs if the efficacy is 100% (i.e. no eggs are counted in the post-treatment samples)  304 
as the upper (UCL) and lower (LCL) limits are then both 100%. This problem also  305 
occurs when using the Lyndal-Murphy et al. (2010) formula for estimating CL. As a  306 
result, CL for 100% efficacy are not reported (eg, Soutello et al., 2007; Lyndal- 307 
Murphy et al., 2010). No CL or CL of 100-100% implies that the 100% efficacy  308 
estimate is equally reliable whether for example a total of 10 or 300 eggs from all  309 
animals were counted pre-treatment; this is not reasonable if the true efficacy was  310 
98% as the expected total count from all animals post-treatment would then be 0.2 and  311 
6 eggs, respectively in this example. Assuming a Poisson distribution of sample  312 
counts approximately 81% and 0.2% of trials will provide an efficacy of 100% if the  313 
expected total count is 0.2 and 6 eggs, respectively for the above example, (i.e. if the  314 
mean count/chamber was 0.2 eggs and 100 chambers were counted, then 19 chambers  315 
would contain 1 or more eggs and the remainder would be zero, assuming that sample  316 
counts have a Poisson distribution.) It is clear that the fewer eggs counted pre- 317 
treatment, the more likely an estimate of 100% will occur particularly if the true  318 
efficacy is greater than say 90%. (This discussion is not referring to 10, 300, 0.2 or 6  319 Page 14 of 47
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as the number of eggs per gram but as the total eggs counted over all animals in a test  320 
group pre- or post-treatment.)  321 
  322 
A proposed approach to solve this problem is to estimate the LCL for a binomial  323 
proportion using methods described by Brown et al. (2001), who coined the name  324 
‘Jeffreys interval’ to describe a confidence interval (CI) derived from Bayesian  325 
procedures assuming non-informative priors. The Jeffreys interval is simple to  326 
calculate as the uncertainty about the binomial proportion is described by the beta  327 
distribution, which is a standard function in the Excel spreadsheet (as is the inverse- 328 
beta function). The Jeffreys interval can be reframed in terms of a FECRT by  329 
defining: n as the total number of eggs counted pre-treatment, x the total number of  330 
eggs counted post-treatment, p the proportion of resistant eggs is p=x/n and percent  331 
efficacy is 100*(1-p). The LCL can be approximated from the cumulative inverse beta  332 
distribution as:  333 
 (1-α)%LCL = 100*(1-(BETAINV(1-α/2, x+1, n-x+1))) equation  (1)  334 
 (1-α)%UCL = 100*(1-(BETAINV(α/2, x+1, n-x+1))) equation  (2),  335 
where α is the significance level used to define the CI and the percent CI is 100*(1- 336 
α), e.g. α=0.05 and 0.01 for 95% and 99%CL, respectively. BETAINV is the  337 
cumulative distribution function for the beta distribution specified by the latter two  338 
parameters (i.e. x+1and n-x+1) of the three mandatory Excel parameters in the  339 
equations above. The Jeffreys interval defined by Brown et al. (2001) uses 0.5 (e.g.  340 
x+0.5) rather than 1 (e.g. x+1) as the non-informative prior, as the 0.5 prior provides a  341 
better estimate of the UCL for small n, however a prior of 1 was chosen as it provides  342 
a more conservative LCL, particularly for n<40 eggs; there is little difference between  343 Page 15 of 47
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the results from the two priors for larger n. Figure 1 shows the LCL for 100% efficacy  344 
using equation (1) for varying numbers of eggs counted pre-treatment.  345 
  346 
A minimum requirement to estimate efficacy with reasonable accuracy  347 
(95%LCL>95% efficacy) is that no fewer than a total of 70 eggs should be counted in  348 
the pre-treatment counts (Figure 1). If 90% efficacy were an acceptable 95%LCL then  349 
at least 37 eggs need to be counted pre-treatment (i.e. a total 37 eggs counted from all  350 
animals and egg count chambers). Figure 1 provides a useful guide to the precision of  351 
a FECRT when the observed efficacy is 100% unlike the current methods (Coles et  352 
al., 1992; Lyndal-Murphy et al., 2010) that provide no estimate of precision when  353 
efficacy is 100%.  354 
  355 
4.2 When the efficacy estimate is less than 100%  356 
To more generally apply this method for efficacy <100% (i.e. for p>0) it is required  357 
that the samples are drawn from the same animals pre- and post-treatment, and are  358 
counted at the same level of sensitivity (i.e. the same number of chambers per animal  359 
are counted at the same detection level pre- and post-treatment). This requirement was  360 
relaxed for 100% efficacy as rough approximation of precision is better than no  361 
approximation of test reliability, which is the current situation. An example; if a total  362 
of 100 eggs (n) and 10 eggs (x) were counted pre- and post-treatment, respectively  363 
from the same animals then the efficacy is 90% and for α=0.05 the CL are computed  364 
in Excel using equations (1) and (2) by:  365 
  95%LCL = 100*(1-(BETAINV(0.975, 11, 91))) = 83%  366 
  95%UCL = 100*(1-(BETAINV(0.025, 11, 91))) = 94%  367 
  368 Page 16 of 47
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Figure 2 shows the Jeffreys intervals for 95% and 90% efficacy, and can be used as a  369 
guide to required FECRT precision. For example, approximately 140 eggs are  370 
required to estimate 95% efficacy with CLs 90-98%, this equates to a mean epg of  371 
700 or 350 for a detection factor of 50 or 25, respectively assuming 10 animals per  372 
group. If the basic requirements for a FECRT are considered then from Figures 1 and  373 
2, a minimum total of 70 eggs counted pre-treatment would be adequate to provide  374 
reasonable precision. While this is subjective and the purpose of the FECRT may  375 
influence the level of precision required, Figures 1 and 2 provide a useful guide. The  376 
Jeffreys interval is not defined when efficacy is less than zero, i.e. when the post- 377 
treatment count is greater than the pre-treatment count. However, in this situation the  378 
drug is clearly useless and the LCL and UCL were arbitrarily set to zero.  379 
  380 
The Jeffreys interval approach was compared with the current statistical method  381 
(Coles et al. 1992) using unpublished nematode characterisation data covering a wide  382 
range of drug efficacies (supplied by Novartis Animal Health Australasia Pty  383 
Limited). The test protocol consisted of three animals in each treated and control  384 
group, for 52 data sets including 35 and 17 susceptible and resistant cases,  385 
respectively. Nine data sets were from cattle and the remainder from sheep, covering  386 
10 nematode species and the ML, BZ and LEV drug groups, including some tests with  387 
BZ+LEV combinations. Of these cases 24, 11, 4, 4 and 9 had efficacies of 100%,  388 
<100 to 95%, <95 to 90%, <90 to 60% and <60%, respectively, determined from  389 
controlled slaughter studies. Egg counts were also performed pre- and post-treatment  390 
on all groups. Detection levels for cattle were 20 for both worm and egg counts, for  391 
sheep these were 20 and 50 for worm and egg counts, respectively. A mean of 128  392 
eggs was observed pre-treatment, however, in 35% of the data sets fewer than 25 eggs  393 Page 17 of 47
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were counted pre-treatment for some species (e.g. Nematodirus, Cooperia,  394 
Trichostrongylus axei).  395 
  396 
These data were used to estimate specificity (Sp) and sensitivity (Se) of FECRT 2 and  397 
3 as defined by per McKenna (2006; see Section 3 above). In addition, the error rate  398 
(accuracy) and precision of using the 99 and 95% Jeffreys CI was compared with the  399 
95% RESO CI (Coles et al., 1992). Precision was estimated by the average width of  400 
the FECRT CI and error rate was defined as the percent of times the FECRT CI did  401 
not include the efficacy determined from worm count data.  402 
  403 
Table 3 gives the results of this analysis and show that Sp and Se were very similar to  404 
those estimated by McKenna (2006). The average width of the 99% Jeffreys FECRT  405 
3 CI was 7% less than the 95% RESO FECRT 2 CI and the error rate for FECRT3  406 
was 10% less that for FECRT2. The mean 95% Jeffreys CI was 5% less than the mean  407 
99% Jeffreys CI, but this did not change the FECRT3 values for Se, Sp or error rate  408 
(data not shown). One important difference was observed for error rate: for FECRT 2  409 
11 of the 13 errors occurred when efficacy was in the range <100 to 95% (in all 11  410 
cases UCL=LCL=100% as determined by RESO), while seven of the eight errors for  411 
FECRT 3 occurred when efficacy was below 60% (in five of these seven cases the  412 
efficacy was <0% and thus UCL=LCL=0% for Jeffreys CL).  413 
  414 
In summary, FECRT 3 (comparisons of pre- and post-treatment counts without  415 
controls) better estimated efficacy than FECRT 2 (post treatment counts only with a  416 
control) when efficacy was moderate to high (above 60%), though neither falsely  417 
declared resistance when a strain was susceptible (Sp=100%). FECRT 2 more  418 Page 18 of 47
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accurately estimated efficacy than FECRT 3 when efficacy was below 60%. When the  419 
efficacy was between 80 and 95%, FECRT 2 and FECRT3 mis-diagnosed resistant  420 
isolates in two and one test, respectively. The high Sp and Se observed here for  421 
FECRT were based on experimental infections and probably represent the best  422 
possible values, and in the field lower values could be expected.  423 
  424 
4.3 Comparison of Jeffreys interval with Monte Carlo techniques from cattle data  425 
A survey for cattle anthelmintic resistance using FECRT was conducted by El- 426 
Abdellati et al. (2010). Preference was given to sampling as many farms as possible  427 
by sampling 10 cattle per treatment group at a detection level of 50 epg. The same  428 
groups of animals were tested pre- and post-treatment but the same 10 animals were  429 
not necessarily sampled (a mix of FECRT3-4 as defined in Section 3). The authors  430 
were concerned with falsely declaring reduced anthelmintic efficacy (the opposite  431 
issue to that discussed in Section 4.1). Using Monte Carlo simulation techniques they  432 
generated the distribution of results for their sampling protocol for a drug with 95%  433 
efficacy (10,000 iterations per treatment group). If the observed efficacy was in the  434 
lowest 5% of the simulated distribution then reduced efficacy was assumed.  435 
  436 
Even though the same animals were not tested pre- and post-treatment the UCL for  437 
their observed efficacies was approximated by:  438 
UCL=100*(1-(BETAINV(c,x+1,n-x+1))),  where c was set at 0.005, 0.025 and 0.05  439 
for 99%, 95% and ‘1 tail 95%’ UCL, respectively; total eggs counted pre-treatment  440 
(n) and total eggs found post-treatment (x) for each farm were estimated by:   441 
n=epg*10/50 and x= n*(%efficacy/100). The criteria using were: if the observed  442 
efficacy’s UCL was less than 95%, then the farm had a significant reduction in drug  443 Page 19 of 47
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efficacy. Of the 33 farms with mean efficacy <95%, the 99% and 95% Jeffreys  444 
interval classified 32 and 31 of the farms, respectively, which was the number  445 
classified by Monte Carlo simulation. Given that the latter required 10,000 iterations  446 
to obtain a single result the Jeffreys method provided a simple rapid estimate of CL  447 
for this data, despite pre- and post-treatment counts coming from different animals.  448 
The Jeffreys method should not be used to estimate CL if control or pre-treatment  449 
animals are different individuals to the treated animals (i.e. FECRT 2 and 4). The  450 
mean total eggs counted pre-treatment by El-Abdellati et al. (2010) for these farms  451 
was 25, which generally provides low precision for an assay as can be seen from  452 
Figure 2. In 58% of the data sets fewer than 25 eggs were counted pre-treatment and  453 
on only three occasions were more than 40 eggs counted pre-treatment. This further  454 
demonstrates that it is as important to establish a minimum number of eggs to count in  455 
an assay as it is to set a minimum group size, particularly for cattle.  456 
  457 
4.4 Use of Jeffreys interval with cattle and horse field data  458 
4.4.1 Cattle data  459 
Unpublished results from one farm in a survey of anthelmintic resistance in Western  460 
Australian cattle conducted by the Department of Agriculture and Food WA in 2010  461 
were made available to the authors for comparisons of FECRT methods, including the  462 
Jeffreys interval. The particular farm was selected because it contained multiple  463 
species and reduced efficacy for some drugs. The survey adopted a relatively high  464 
precision protocol by sampling a minimum of 15 animals per group (up to 20) and a  465 
detection level of 12.5 epg, using a modified McMaster egg count procedure and  466 
counting two chambers per animal. Egg counts were conducted pre- and post- 467 
treatment for treated and untreated control animals. Faecal culture and larval  468 Page 20 of 47
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differentiation were carried out on all groups pre- and post-treatment. At the pre- 469 
treatment count five animals with the highest counts were identified and six additional  470 
chambers were counted for these animals. At the post-treatment counts these animals  471 
were counted as usual plus six additional chambers were counted. This process  472 
increased the effective detection level to approximately 3 epg for the animals with  473 
high egg counts. The aim here was to compare three procedures to estimate the  474 
efficacy and 95%CL:  475 
Method-1, the standard estimate (FECRT 2, defined above) and analysing the results  476 
using RESO as per Coles et al (1992);  477 
Method-2, FECRT 3, but using the Jeffreys interval;  478 
Method-3, determining efficacy and 95%CL only from the five animals with the  479 
highest counts and additional chambers counted and using the Jeffreys interval to  480 
estimate the 95%CL (i.e. additional chambers counted to increase the total number of  481 
eggs observed to improve the FECRT precision).  482 
  483 
The efficacy results for the three methods are shown in Table 4, using the criteria  484 
defined by Coles et al. (1992): “Resistance is present if (i) the percentage reduction in  485 
egg count is less than 95% and (ii) the 95% confidence level is less than 90%. If only  486 
one of the two criteria is met resistance is suspected.” For undifferentiated total egg  487 
count, only Method-3 estimated an efficacy of <100% for ivermectin (IVM)  488 
injectable; fenbendazole (FBZ) was categorised as ‘suspect resistant’ by Method-1 but  489 
not by Method-2 or 3; LEV was considered ‘resistant’ by Method-1 and Method- 2  490 
and ‘suspect’ by Method-3. Methods-1 and 2 categorised Ostertagia eggs ‘FBZ- 491 
resistant’ while Method-3 found the Ostertagia population to be ‘susceptible’  492 Page 21 of 47
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(efficacy 95.8% and 95%LCL 90.5%). Only Method-3 found an efficacy of <100%  493 
for IVM injectable against Cooperia eggs.  494 
  495 
For the control group a total of 120 eggs was recovered from 18 animals; when  496 
converted to mean eggs per gram (83 epg) to determine efficacy, as required for  497 
Method-1, efficacy would be overestimated for IVM injectable with mean 65 epg and  498 
underestimated for FBZ, LEV and IVM pour-on with mean epg of 108, 138 and 155,  499 
respectively. Methods-2 and 3 both resolve this problem.  500 
  501 
Low numbers of Oesophagostomum were found on this farm (mean 7% pre-treatment  502 
and 0% post-treatment), indicating that all drugs were 100% effective against this  503 
parasite and a LCL of 100% for Method-1. However it would not be appropriate to  504 
report this result to the stock owner, as Method-2 indicated a 95%LCL <60% for FBZ  505 
and IVM injectable, 84% for LEV and 90% for IVM pour-on. Method-3 provides  506 
slightly more confidence in the results with a 95%LCL of the four treatments of 84%,  507 
81%, 93% and 95%, respectively. It would be reasonable to report a result of 100%  508 
efficacy if the Jeffreys 95%LCL was above 90%, but otherwise a result of  509 
‘insufficient data or worm eggs’ should be reported.  510 
  511 
Under this protocol, if the three Methods were used in isolation then Method-1 would  512 
require the least work, i.e. 200 chambers counted (2-chambers x 5-groups x 20- 513 
animals x 1-time-post-treatment). Method-2 requires 320 chambers to be counted (2- 514 
chambers x 4-groups x 20-animals x 2-times) or 60% more work than Method-1.  515 
Method-3 requires 440 chambers be counted (2-chambers x 4-groups x 20-animals x  516 
1-time-pre-treatment + 6-chambers x 4-groups x 5-animals x 1-time-pre-treatment +  517 Page 22 of 47
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8-chambers x 4-groups x 5-animals x 1-time-post-treatment), i.e. 2.2 times more effort  518 
than Method-1 and 38% more than Method-2. To determine if the additional work  519 
provided more information, the total eggs counted by each method can be compared  520 
after correction to 20 animals/group (e.g. for the control group, 120 eggs were  521 
counted from 18 animals; if 20 animals were counted this would then increase to  522 
approximately 133 eggs). The mean number of pre-treatment eggs counted for the five  523 
Method-3 animals was 439/group, indicating that 2.2 times more work than Method-1  524 
yielded 3.3 times more eggs. For Method-2, the mean number of eggs counted pre- 525 
treatment was 186 (after correction to 20 animals), so that Method-3 yielded 2.4 times  526 
more eggs for 38% more work. Conditions which may justify the additional work to  527 
increase the precision of an assay are discussed below (Section 4.5.3 and Conclusion).  528 
  529 
4.4.2 Horse data  530 
On many properties, relatively few horses are present, making the routine FECRT  531 
(McKenna 2006) difficult to conduct. Even for farms where large numbers of horses  532 
are present, the numbers in homogeneous groups suitable for FECRT (i.e. similar age,  533 
blood line and grazing and treatment history) are usually relatively small compared  534 
with sheep and cattle. In this situation Jeffreys interval can provide estimates of test  535 
precision. Table 5 shows nematode FECRT data from seven horse owners in the Perth  536 
region of WA; because the drug efficacy was generally 100% only the LCL are  537 
shown.  538 
  539 
As discussed in Section 4.1 the standard method (RESO; Coles et al 1992) cannot  540 
provide helpful CI when efficacy is 100%. On the seven farms LCL were able to be  541 
determined by Jeffreys interval but only on one farm could RESO estimate a LCL.  542 Page 23 of 47
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  543 
4.5 Precision and error rate for Jeffreys interval and standard statistical methods  544 
4.5.1 Method  545 
For the purpose of comparing Jeffreys interval with the standard statistical approach  546 
(Coles et al., 1992),‘precision’ was defined as the width of the CI and ‘error rate’ the  547 
percentage of results where the true efficacy lies outside the CL of the estimated  548 
efficacy. As CI=UCL-LCL, the wider the CI, the chance of error is reduced but  549 
precision is sacrificed. Comparing the error rate and precision of Methods-1, 2 and 3  550 
(Section 4.4) requires Monte Carlo simulations where the true efficacy, sampling  551 
variability, mean egg count and distribution of counts in the host population are  552 
defined. Variability in simulation results follow from random selection of 10 hosts  553 
from the population with known k for the Negative Binomial Distribution (NBD) and  554 
laboratory sampling variability associated with the Poisson distribution of egg counts  555 
(Dobson et al., 2009). Four scenarios were simulated: k for the NBD either set at 0.5  556 
or 2, both with low and high sensitivity for detecting nematode eggs. For low  557 
sensitivity the mean epg was set at 250 with a detection factor of 50, i.e. the expected  558 
count per animal was five eggs or a total of 50 eggs observed pre-treatment if 10  559 
animals were used. For high sensitivity the mean epg was set at 300 with a detection  560 
factor of 25, i.e. the expected count per animal was 12 eggs or a total of 120 eggs  561 
observed pre-treatment if 10 animals were used. The Monte Carlo methods of Dobson  562 
et al. (2009) were used to generate 10,000 results for each simulation scenario;  563 
efficacy and CL were estimated at each iteration by the three methods. For Method-2,  564 
that requires pre- and post-treatment counts from the same animals (FECRT 3), CL  565 
were estimated by both the Jeffreys and RESO (Coles et al., 1992) methods. For  566 
Method-3, three additional counts of the two, three, four or five of the highest egg  567 Page 24 of 47
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shedding animals from the 10 randomly selected animals was simulated by drawing  568 
additional Poisson samples at the appropriate detection level. This process changed  569 
the detection factors of 50 and 25 to 12.5 and 6.25 epg, respectively for the high egg  570 
shedding animals. For Jeffreys CI both 99% and 95%CI were determined (α = 0.01  571 
and 0.05, respectively), for RESO only 95%CI were calculated. As noted, Jeffreys  572 
interval can only be used when the same animals are counted pre- and post-treatment,  573 
and the calculations therefore cannot be applied to Method-1 data. In the simulations,  574 
true efficacy was set at 95% as it is preferable to detect resistance while efficacy is  575 
relatively high rather than when it declines to low levels that risk parasitism and  576 
production losses.  577 
  578 
4.5.2 Results  579 
Table 6 shows the mean width of the CI and error rate for each scenario and method.  580 
The error rate for the 95% Jeffreys CI was about 6% and was reasonably consistent  581 
across scenarios and methods. This was approximately half the error rate for the  582 
standard method (RESO; Coles et al., 1992) at low assay sensitivity but was generally  583 
higher than the RESO error rate at high assay sensitivity (see Table 6). The precision  584 
of the 95% Jeffreys CI, measured by the width of the CI, was approximately 50%  585 
better (smaller) than the RESO 95%CI. By determining the 99% Jeffreys CI, the  586 
width of the CI only increased by about 2-4% on average (minimal loss of precision)  587 
but was still substantially smaller than the RESO 95%CI. The error rate associated  588 
with the 99% Jeffreys CI was about 1.4% and was lower than the RESO error rate for  589 
all scenarios and methods except for the high sensitivity pre- and post-treatment  590 
(Method-2) with k=2, which had the same low error rate as the Jeffreys results. By  591 
restricting the Jeffreys estimates to data only from either the two, three, four or five  592 Page 25 of 47
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animals with the highest egg counts (Method-3) there was little impact on the error  593 
rate while the precision improved slightly as more animals were included in the  594 
FECRT. Figure 3 shows the distribution of Monte Carlo efficacy results for each  595 
method at the high sensitivity FECRT level and for k=0.5, the frequency bar at 81%  596 
efficacy includes efficacy results less than 81%. Figure 3 shows that efficacies based  597 
on pre- and post-treatment counts are more closely distributed about the true efficacy  598 
(95%) than results obtained from control and treated groups. Additional improvement  599 
in the distribution was obtained by Method-3. The equivalent distributions for k=2  600 
(data not shown) shows no difference between the two pre- and post-treatment  601 
methods (Methods-2 and 3) but both were better than Method-1.  602 
  603 
4.5.3 Discussion  604 
Morgan et al. (2005) found k for the NBD to range from 2.3 to 0.18 in 14 flocks of  605 
commercially managed sheep. In four lamb flocks k was >1 with mean 1.8. In the  606 
remaining three ewe flocks and seven lamb flocks the range for k was 0.63 to 0.18  607 
with mean 0.38, with these low values for k associated with low egg counts (<400  608 
epg). For sheep, it is therefore not unreasonable to expect to encounter some groups of  609 
animals that have k<0.6, and the situation in cattle, where egg counts are generally  610 
lower, would expected to be associated with similar or lower k values. In the FECRT  611 
simulations the choice of k=2 represents a optimal situation where within group egg  612 
counts would be relatively homogenous, while setting k=0.5 represents a more  613 
difficult situation where some animals with zero epg are likely to be found in the pre- 614 
treatment egg counts (Dobson et al., 2009). In the field it is not possible to know what  615 
k for the NBD is associated with a particular FECRT, however if some animals have  616 
very low or zero counts pre-treatment then k is likely to be low. In this situation pre-  617 Page 26 of 47
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and post-treatment counts on the same animals are essential to estimate efficacy with  618 
reasonable accuracy (Figure 3) and the accuracy can be further improved by using  619 
Jeffreys method to determine the 99%CI as it provides smaller error rates and CI  620 
when efficacy is moderate to high (above 60%). Restricting sampling to the animals  621 
with the highest counts and counting these animals at a higher level of sensitivity will  622 
improve precision. It is futile to retain in a FECRT animals that have low or zero  623 
counts pre-treatment as they contribute very little or nothing to the estimation of  624 
efficacy. Expanding the RESO CI from 95 to 99% would have reduced its error rate  625 
but increased the size of the CI, which were already substantially larger than the  626 
Jeffreys intervals. On the other hand, if counts are high and with relatively low  627 
variation between animals then any of the methods recommended by McKenna (2006)  628 
would yield a suitable result. However, a method that only relies on post-treatment  629 
counts (FECRT 2) would fail to identify the difficult tests where k is low, thus  630 
remedial action, as suggested above, can not be taken to avoid a low precision test.  631 
  632 
5. Conclusion  633 
The onset of anthelmintic resistance to a new highly effective drug (MPL) and the  634 
currently available drugs was delayed by applying all four drug classes for all  635 
anthelmintic treatments. A rapid rotation between MPL and a triple combination  636 
(BZ+LEV+ABA) generally was the next best option. However, in areas where  637 
Haemonchus was a high risk, inclusion of a persistent drug (MOX) in the rotation was  638 
necessary to reduce production losses and additional grazing management may also be  639 
beneficial in this situation. Even though resistance to BZ and LEV was assumed to be  640 
relatively high they were still useful in helping to delay anthelmintic resistance to  641 
other drugs when used as components of a triple combination. Leaving up to 4% of  642 Page 27 of 47
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adult sheep untreated generally helped delay selection for resistance without  643 
compromising nematode control. A strategy that provides a source of refugia is  644 
essential when a combination treatment is used.  645 
  646 
In FECRT where efficacy is estimated to be 100% the current statistical methods fail  647 
to provide CL. In this case the Jeffreys interval provides a simple way to estimate the  648 
precision of the test. There is no evidence that correcting FECRT data for changes in  649 
control egg counts improves the estimate of drug efficacy, and efficacy based on pre- 650 
treatment counts are likely to be more reliable. For FECRT involving pre- and post- 651 
treatment counts of the same animals the 99% Jeffreys interval generally had higher  652 
precision with the least error rate by comparison with the current statistical methods  653 
(RESO; Coles et al., 1992). When conducting a FECRT it is reasonable to assume that  654 
k for the NBD is low when there are zero counts in the pre-treatment animals. In this  655 
situation restricting the test to animals with high counts, increasing the sensitivity of  656 
the counting procedure and using Jeffreys interval to estimate the 99% CL will  657 
improve the precision and accuracy of the FECRT.  658 
  659 
Conflict of interest  660 
The authors declare there is no conflict of interest.  661 
  662 
Acknowledgements  663 
Robert Dobson is grateful to Novartis Animal Health Inc., Basel, Switzerland and  664 
Novartis Animal Health Australasia Pty Limited for funding his position at Murdoch  665 
University while undertaking the modelling studies. Stephen Love from Industry and  666 
Investment New South Wales, John Larsen from The Mackinnon Project, University  667 Page 28 of 47
Accepted Manuscript
   28 
of Melbourne, and Peter Rolfe and Justin Bailey from Novartis Animal Health  668 
Australasia Pty Limited, were key participants in the simulation studies aimed at  669 
slowing the development of anthelmintic resistance in Australia. We are grateful to  670 
Jill Lyon and parasitology staff from the Department of Agriculture and Food Western  671 
Australia for technical assistance and data preparation.  672 
  673 
References  674 
Anderson, N., Martin, P.J., Jarrett, R.G., 1988. Mixtures of anthelmintics: a strategy  675 
against resistance. Aust. Vet. J. 65, 62–63.  676 
  677 
Anderson, N., Martin, P.J., Jarrett, R.G., 1991. The efficacy of mixtures of  678 
albendazole sulphoxide and levamisole against sheep nematodes resistant to  679 
benzimidazole and levamisole. Aust. Vet. J. 68, 127–132.  680 
  681 
Barnes, E.H., Dobson, R.J., 1990. Population dynamics of Trichostrongylus  682 
colubriformis in sheep: computer model to simulate grazing systems and the evolution  683 
of anthelmintic resistance. Int. J. Parasitol. 20, 823–831.  684 
  685 
Barnes, E.H., Dobson, R.J., Barger, I.A., 1995. Worm control and anthelmintic  686 
resistance: adventures with a model. Parasitol. Today.11, 56–63.  687 
  688 
Besier, R.B., Love S.C.J., 2003. Anthelmintic resistance in sheep nematodes in  689 
Australia: the need for new approaches. Aust. J. Expt. Ag. 43, 1383–1391.  690 
  691 Page 29 of 47
Accepted Manuscript
   29 
Besier R.B, Love R.J., Lyon J., van Burgel A.J., 2010. A targeted selective treatment  692 
approach for effective and sustainable sheep worm management: investigations in  693 
Western Australia. Anim. Prod. Sci. 50, 1034-1042.  694 
  695 
Brown, L.D., Cai, T.T., DasGupta, A., 2001. Interval Estimation for a Binomial  696 
Proportion. Statistical Sci. 16, 101–133.  697 
  698 
Cabaret, J., Berrag, B., 2004. Faecal egg count reduction test for assessing  699 
anthelmintic efficacy: average versus individually based estimations. Vet. Parasitol.  700 
121, 105–113.   701 
  702 
Coles, G.C., Bauer, C., Borgsteede, F.H., Geerts, S., Klei, T.R., Taylor, M.A., Waller,  703 
P.J., 1992. World Association for the Advancement of Veterinary Parasitology  704 
(W.A.A.V.P.) methods for the detection of anthelmintic resistance in nematodes of  705 
veterinary importance. Vet. Parasitol. 44, 35–44.  706 
  707 
Coles, G.C., Roush, R.T., 1992. Slowing the spread of anthelmintic resistant  708 
nematodes of sheep and goats in the United Kingdom. Vet. Rec. 130, 505–510.  709 
  710 
Comins, H.N., 1977. The management of pesticide resistance. J. Theo. Biol. 65, 399– 711 
420.  712 
  713 
Comins, H.N., 1986. Tactics for resistance management using multiple pesticides.  714 
Agric. Ecosyst. Environ. 16, 129–148.  715 
  716 Page 30 of 47
Accepted Manuscript
   30 
Cringoli, G., Rinaldi, L., Veneziano, V., Mezzino L., Vercruysse J., Jackson F., 2009.  717 
Evaluation of targeted selective treatments in sheep in Italy: Effects on faecal worm  718 
egg count and milk production in four case studies. Vet. Parasitol. 164, 36–43.  719 
  720 
Dash, K.M., 1986. Control of helminthosis in lambs by strategic treatment with  721 
closantel and broad spectrum anthelmintics. Aust. Vet. J. 63, 4–8.  722 
  723 
Dash, K.M., Hall, E., Barger, I.A., 1988. The role of arithmetic and geometric mean  724 
worm egg counts in faecal egg count reduction tests and in monitoring strategic  725 
drenching programs in sheep. Aust. Vet. J. 65, 66–68.  726 
  727 
Denwood, M.J., Reid, S.W.J., Love, S., Nielsen, M.K., Matthews, L., McKendrick,  728 
I.J., Innocent, G.T., 2010. Comparison of three alternative methods for analysis of  729 
equine Faecal Egg Count Reduction Test data. Prevent. Vet. Med. 93, 316–323.  730 
  731 
Dobson, R.J., LeJambre, L., Gill, J.H., 1996. Management of anthelmintic resistance:  732 
inheritance of resistance and selection with persistent drugs. Int. J. Parasito. 26, 993– 733 
1000.  734 
  735 
Dobson, R.J., Besier, R.B., Barnes, E.H., Love, S.C.J., Vizard, A., Bell, K., Le  736 
Jambre, L.F., 2001. Principles for the use of macrocyclic lactones to minimise  737 
selection for resistance. Aust. Vet. J. 79, 756–761.  738 
  739 Page 31 of 47
Accepted Manuscript
   31 
Dobson, R.J., Sangster, N.C., Besier, R.B., Woodgate, R.G., 2009. Geometric means  740 
provide a biased efficacy result when conducting a faecal egg count reduction test  741 
(FECRT). Vet. Parasitol. 161, 162–167.  742 
  743 
Dobson, R.J., Hosking, B.C., Besier, R.B., Love, S., Larsen, J.W.A., Rolfe, P.F.,  744 
Bailey, J.N., 2011. Minimising the development of anthelmintic resistance, and  745 
optimising the use of the novel anthelmintic monepantel, for the sustainable control of  746 
nematode parasites in Australian sheep grazing systems. Aust. Vet. J. 89, 159–165.  747 
  748 
Dobson, R.J., Barnes, E.H., Tyrrell, K.L., Hosking, B.C., Larsen, J.W.A., Besier,  749 
R.B., Love, S., Rolfe, P.F., Bailey, J.N., 2011. A multi-species model to assess the  750 
effect of refugia on worm control and anthelmintic resistance in sheep grazing  751 
systems. Aust. Vet. J. 89, 200–208.  752 
  753 
El-Abdellati, A., Charlier, J., Geldhof, P., Levecke, B., Demeler, J., von Samson- 754 
Himmelstjerna, G., Claerebout, E., Vercruysse, J., 2010. The use of a simplified  755 
faecal egg count reduction test for assessing anthelmintic efficacy on Belgian and  756 
German cattle farms. Vet. Parasitol. 169, 352–357.  757 
  758 
Gettinby, G., Soutar, A., Armour, J., Evans P., 1989. Anthelmintic resistance and the  759 
control of ovine ostertagiasis: a drug action model for genetic selection. Int. J.  760 
Parasitol. 19, 369–376.  761 
  762 Page 32 of 47
Accepted Manuscript
   32 
Hoste, H., Le Frileux, Y., Pommaret, A., 2002. Comparison of selective and  763 
systematic treatments to control nematode infections of the digestive tract in dairy  764 
goats. Vet. Parasitol. 106, 345–355.  765 
  766 
Jabbar, A., Kerboeuf, D., Muhammad, G., Khan, M.N., Afaq, M., 2006. Anthelmintic  767 
resistance: the state of play revisited. Life Sci. 79, 2413–2431.  768 
  769 
Kaminsky, R., Gauvry, N., Schorderet Weber, S., Skripsky, T., Bouvier, J., Wenger,  770 
A., Schroeder, F., Desaules, Y., Hotz, R., Goebel, T., Hosking, B.C., Pautrat, F.,  771 
Wieland-Berghausen, S., Ducray, P., 2008. Identification of the amino-acetonitrile  772 
derivative monepantel (AAD 1566) as a new anthelmintic drug development  773 
candidate. Parasitol. Res. 103, 931–939.  774 
  775 
Kaplan, R.M., 2004. Drug resistance in nematodes of veterinary importance: a status  776 
report. Trends Parasitol. 20, 477–481.  777 
  778 
Lawrence, K.E., Rhodes, A.P., Jackson, R., Leathwick, D.M., Heuer, C., Pomroy,  779 
W.E., West, D.M., Waghorn, T.S., Moffat, J.R., 2006. Farm management practices  780 
associated with macrocyclic lactone resistance on sheep farms in New Zealand. N.Z.  781 
Vet. J. 54, 283–288.  782 
  783 
Leathwick, D.M., Miller, C.M., Atkinson, D.S., Haack, N.A., Alexander, R.A.,  784 
Oliver, A-M, Waghorn, T.S., Potter, J.F., Sutherland, I.A., 2006a. Drenching adult  785 
ewes: Implications of anthelmintic treatments pre- and post-lambing on the  786 
development of anthelmintic resistance. N.Z. Vet. J. 54, 297–304.  787 Page 33 of 47
Accepted Manuscript
   33 
  788 
Leathwick, D.M., Waghorn, T.S., Miller, C.M., Atkinson, D.S., Haack, N.A., Oliver  789 
A-M., 2006b. Selective and on-demand drenching of lambs: Impact on parasite  790 
populations and performance of lambs. N.Z. Vet. J. 54, 305–312.  791 
  792 
Leathwick, D.M., Hosking, B.C., 2009. Managing anthelmintic resistance: Modelling  793 
strategic use of a new anthelmintic class to slow the development of resistance to  794 
existing classes. N.Z. Vet. J. 57, 203–207.  795 
  796 
Leathwick, D.M., Hosking, B.C., Bisset, S.A., McKay, C.H., 2009a. Managing  797 
anthelmintic resistance: Is it feasible in New Zealand to delay the emergence of  798 
resistance to a new anthelmintic class? N.Z. Vet. J. 57, 181–192.  799 
  800 
Leathwick, D.A., Vlassoff, A., Barlow, N.D., 1995. A model for nematodiasis in New  801 
Zealand lambs: The effect of drenching regime and grazing management on the  802 
development of anthelmintic resistance. Int. J. Parasitol. 25, 1479–1490.  803 
  804 
Le Jambre, L.F., Southcott, W.H., Dash, K.M., 1977. Resistance of selected lines of  805 
Ostertagia circumcincta to thiabendazole, morantel tartrate and levamisole. Int. J.  806 
Parasitol. 7, 473–479.  807 
  808 
Le Jambre, L.F., Southcott, W.H., Dash, K.M., 1978. Development of simultaneous  809 
resistance in Ostertagia circumcincta to thiabendazole, morantel tartrate and  810 
levamisole. Int. J. Parasitol. 8, 443–447.  811 
  812 Page 34 of 47
Accepted Manuscript
   34 
Lyndal-Murphy, M., Rogers, D., Ehrlich, W.K., James, P.J., Pepper, P.M., 2010.  813 
Reduced efficacy of macrocyclic lactone treatments in controlling gastrointestinal  814 
nematode infections of weaner dairy calves in subtropical eastern Australia. Vet.  815 
Parasitol. 168, 146–150.  816 
  817 
Mani, G.S., 1985. Evolution of resistance in the presence of two insecticides.  818 
Genetics. 109, 761–783.  819 
  820 
McKenna, P.B., 2006. Further comparison of faecal egg count reduction test  821 
procedures: Sensitivity and specificity. N.Z. Vet. J. 54, 365–366.  822 
  823 
Morgan, E.R., Cavill, L., Curry, G.E., Wood, R.M., Mitchell, E.S.E., 2005. Effects of  824 
aggregation and sample size on composite faecal egg counts in sheep. Vet. Parasitol.  825 
131, 79–87.  826 
  827 
Pech, C.L., Doole, G.J., Pluske, J.M., 2009. Economic management of anthelmintic  828 
resistance: model and application. Aust. J. of Agric. & Res. Econ. 53, 585–602.  829 
  830 
Presidente, P.A., 1985. Methods for detection of resistance to anthelmintics. In:  831 
Anderson, N., Waller, P.J. (eds). Resistance in Nematodes to Anthelmintic Drugs. Pp  832 
13–27. CSIRO Division of Animal Health, and Australian Wool Corporation, Glebe,  833 
NSW, Australia.  834 
  835 
Prichard, R.K., Hall, C.A., Kelly, J.D., Martin, I.C.A., Donald, A.D., 1980. The  836 
problem of anthelmintic resistance in nematodes. Aust. Vet. J.56, 239–251.  837 Page 35 of 47
Accepted Manuscript
   35 
  838 
Roush, R.T., 1989. Designing resistance management programs: how can you choose?  839 
Pesticide Sci. 26, 423–441.  840 
  841 
Smith, G., 1990. A mathematical model for the evolution of anthelmintic resistance in  842 
a direct life cycle nematode parasite. Int. J. Parasitol. 20, 913–921.  843 
  844 
Smith, G., 1998. Factors that may impede or promote the evolution of anthimintic  845 
resistance in the common trichostrongylid nematode parasites of cattle. In:  846 
Proceedings XX World Buiatrics Congress, Sydney, 6–10 July 1998. AACV Sydney  847 
780–784.  848 
  849 
Smith, G., Grenfell, B.T., Anderson, R.M., 1987. Regulation of Ostertagia ostertagi  850 
populations in calves: density dependent control of fecundity. Parasitol. 95, 373–388  851 
  852 
Soutello, R.G.V., Seno, M.C.Z., Amarante, A.F.T., 2007. Anthelmintic resistance in  853 
cattle nematodes in northwestern Sao Paulo State, Brazil. Vet. Parasitol. 148, 360– 854 
364.  855 
  856 
van Wyk, J,A., 2001. Refugia - overlooked as perhaps the most potent factor  857 
concerning the development of anthelmintic resistance. Onder. J. of Vet. Res. 68, 55– 858 
67.  859 
  860 Page 36 of 47
Accepted Manuscript
   36 
van Wyk, J.A., Bath, G.F., 2002. The FAMACHA system for managing  861 
haemonchosis in sheep and goats by clinically identifying individual animals for  862 
treatment. Vet. Res. 33, 509–529.  863 
  864 
Vidyashankar, A.N., Kaplan, R.M., Chan, S., 2007. Statistical approach to measure  865 
the efficacy of anthelmintic treatment on horse farms. Parasitol. 134, 2027–2039.  866 
  867 
Vercruysse, J., Holdsworth, P., Letonja, T., Barth, D., Conder, G., Hamamoto, K.,  868 
Okano, K., 2001. International harmonisation of anthelmintic efficacy guidelines. Vet.  869 
Parasitol. 96, 171–193.  870 
  871 
Waller, P.J., Donald, A.D., Dobson, R.J., Lacey, E., Hennessy, D.R., Allerton, G.R.,  872 
Prichard, R.K., 1989. Changes in anthelmintic resistance status of Haemonchus  873 
contortus and Trichostrongylus colubriformis exposed to different anthelmintic  874 
selection pressures in grazing sheep. Int. J. Parasitol. 19, 99–110.  875 
  876 
Waghorn, T.S., Leathwick, D.M., Miller, C.M., Atkinson, D.S., 2008. Brave or  877 
gullible: Testing the concept that leaving susceptible parasites in refugia will slow the  878 
development of anthelmintic resistance. N.Z. Vet. J. 56, 158–163.  879 
  880 
Wolstenholme, A.J., Fairweather, I., Prichard, R.K., von Samson-Himmelstjerna, G.,  881 
Sangster, N.C., 2004. Drug resistance in veterinary helminths. Trends Parasitol. 20,  882 
469–476.  883 
  884 Page 37 of 47
Accepted Manuscript
   37 
Table 1. 
Recommendations to delay anthelmintic resistance              Reference 
Annual rotation of  unrelated 
anthelmintics 
Prichard et al., 1980; Waller et al., 1989; 
Coles et al., 1992; Barnes et al., 1995. 
Use of anthelmintics in combination   Dash, 1986; Anderson et al., 1989; Smith, 
1990; Barnes et al., 1995; Dobson et al., 
2001; Wolstenholme et al., 2004; 
Leathwick et al., 2009a. 
Specific advice for anthelmintic or sheep 
classes 
Leathwick et al., 1995; Dobson et al., 
2001; Leathwick et al., 2009, 2009a. 
Recommendation to delay pesticide resistance                    Reference 
Use of anthelmintics in combination  Comins, 1977, 1986; Mani, 1985; Roush, 
1989. 
 
 
 
Table 2. Summary examples of low-risk anthelmintic treatment
a programs in key 
sheep farming areas of Australia 
Zone
  Class Oct  Nov  Dec  Feb  Mar Apr May Jun  Jul  Aug 
WA
b  Ewe       COM  MPL    
VIC  Ewe   COM   MPL      COM  
NSW  Ewe    MPL  MOX COM MPL     MOX
NSWr    Ewe    MPL  MOX  MPL     MOX
            
WA  Lamb  MPL   COM     MPL    
VIC  Lamb   COM   MPL    COM    
NSW  Lamb  COM   MPL  MOX COM MPL   MOX    
NSWr    Lamb  MOX   MPL  MOX MPL  MOX     
a Treatments are scheduled to occur at various time points within the months; MPL = 
monepantel; COM = triple combination (BZ+LEV+ABA); MOX = moxidectin. 
b WA = Western Australia; VIC = Victoria; NSW = northern New South Wales (low 
Haemonchus risk); NSWr = northern New South Wales (high Haemonchus risk). 
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Table 3. 
Comparison of diagnostic parameters for FECRT2 (efficacy from post-treatment 
counts of treated and control animals with 95% confidence interval (CI) estimated by 
RESO as per Coles et al. (1992) and FECRT3 (efficacy from pre- and post-treatment 
counts from the same animals using the 99% Jeffreys interval, see text). FECRT 
parameters were tested against efficacy based on worm count data, regarded as the 
‘gold standard’ and drug resistance was defined as per Coles et al. (1992), ie, 
“Resistance is present if (i) the percentage reduction in egg count is less than 95% 
and (ii) the 95% confidence level is less than 90%. 
 
 post/control  post/pre
Parameter FECRT2  FECRT3
aSensitivity 88%  94%
bSpecificity 100%  100%
cCI width  28%  21%
dError rate  25%  15%
a The percent of drug resistant cases, based on worm count data, correctly diagnosed 
as resistant by FECRT2 and FECRT3. 
b The percent of drug susceptible cases, based on worm count data, correctly 
diagnosed as susceptible by FECRT2 and FECRT3. 
c The average width of the CI (precision). 
d The percent of times the CI does not include the efficacy determined from worm 
count data (accuracy). 
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Table 4. 
Example cattle results from an efficacy study on one farm. Efficacy and 95% 
confidence limits (CL) estimated by Method-1 (post/control all animals with RESO 
CL), Method-2 (post/pre all animals with Jeffreys CL) and Method-3 (post/pre 5 
highest animals with Jeffreys CL) (see Section 4.4). Also shown is: the number of 
animals per group; total eggs counted (not epg) pre- and post-treatment; percentage of 
Ostertagia and Cooperia pre- and post-treatment. Results in bold font were resistant 
for criteria (i) efficacy<95% or (ii) LCL<90% (see Section 4.4.1). Results in italic 
font highlight difference between the three methods. 
 
All eggs 
a IVM Inj FBZ LEV IVM PO 
Method-1 %Efficacy  100 96.5 88.5 99.3 
RESO 95%UCL  100 99.1 95.9 99.9 
CL. 95%LCL  100 86.6 68.2 93.4 
Method-2 %Efficacy  100 97.3 92.9 99.6 
Jeffreys 95%UCL  100 98.9 95.8 99.9 
CL. 95%LCL  96.2 93.2 88.3 97.8 
b Number of animals  18 17 17 20 
Total eggs  Pre-treat.  94 147 184 248 
counted. Post-treat.  0 4 13 1 
Method-3 %Efficacy  99.1 98.8 94.1 99.8 
Jeffreys 95%UCL  99.7 99.5 95.9 100 
CL. 95%LCL  97.4 97.3 91.6 99.0 
c Number of animals  5 5 5 5 
Total eggs  Pre-treat.  335 422 472 528 
counted. Post-treat.  3 5 28 1 
 
dOstertagia 
 
Method-1 %Efficacy  100 93.6 79.1 99.1 
RESO 95%UCL  100 98.3 92.5 99.9 
CL. 95%LCL  100 75.7 42.2 92.0 
Method-2 %Efficacy  100 90.3 55.8 99.4 
Jeffreys 95%UCL  100 96.0 72.1 99.9 
CL. 95%LCL  91.1 77.5 38.2 96.0 
Total eggs  Pre-treat.  39 41 29 122 
counted. Post-treat.  0 4 13 1 
Method-3 %Efficacy  100 95.8 62.9 99.7 
Jeffreys 95%UCL  100 98.1 73.0 99.9 
CL. 95%LCL  97.4 90.5 51.6 98.1 
Total eggs  Pre-treat.  137 118 76 259 
counted. Post-treat.  0 5 28 1 
% Ostertagia    Pre-treat. 41% 28% 16% 49% 
% Ostertagia   Post-treat. 0% 100% 100% 67% 
 
dCooperia oncophora 
 
Method-1 %Efficacy  100 100 100 99.3 
RESO 95%UCL  100 100 100 99.9 
CL. 95%LCL  100 100 100 94.2 Page 40 of 47
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Method-2 %Efficacy  100 100 100 99.5 
Jeffreys 95%UCL  100 100 100 99.9 
CL. 95%LCL  92.7 96.4 97.2 94.0 
Total eggs  Pre-treat.  48 98 129 69 
counted. Post-treat.  0 0 0 0 
Method-3 %Efficacy  98.2 100 100 99.8 
Jeffreys 95%UCL  99.4 100 100 100 
CL. 95%LCL  95.0 98.7 98.9 97.1 
Total eggs  Pre-treat.  171 283 330 148 
counted. Post-treat.  3 0 0 0 
%Cooperia       Pre-treat.  51% 67% 70% 28% 
%Cooperia      Post-treat. 100% 0% 0% 33% 
a Anthelmintics used: IVM Inj = ivermectin subcutaneous injectable 10 mg/mL; FBZ 
= fenbendazole 100 mg/L); LEV = levamisole hydrochloride 80 gm/L; IVM PO- = 
ivermectin pour-on 5 mg/mL. Administered doses were as per label recommendations 
for each anthelmintic. 
b The same number of animals shown per anthelmintic treatment group applies to each 
nematode species and Methods-1 and 2. 
c For Method-3 there were five animals per group for all groups and nematode species. 
d Total eggs counted for individual worm species were estimated from the % L3 
recovered in larval cultures. 
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Table 5. 
Individual horse pre-treatment epg and the number eggs counted pre- and post-
treatment (detection factor 12.5 epg). Efficacy and lower confidence limits (LCL) 
were determined for each farm and drug. For RESO (Coles et al., 1992) the 95%LCL 
was estimated, for Jeffreys interval (see text) the 95% and 99%LCL were estimated. 
       Lower  Confidence  Limit
    Pre-treatment  Drug  Post-treatment Jeffreys Jeffreys  RESO
a Farm
  epg eggs 
b used eggs efficacy 95% 99%  95%
1 1250  100  ABA  0  
1 2375  190  ABA  0  
1 2410  193  ABA  0 100 99.7 99.5  100
1 2630  210  ABA  0  
1 2013  161  ABA  0  
1 2575  206  ABA  0  
2 525  42  MOX  0 100 91.8 88.4 
c NA
 
3 1150  92  MOX  0  
3 488  39  MOX  0  
3 400  32  MOX  0 100 98.8 98.3  100
3 1350  108  MOX  0  
3 500  40  MOX  0  
3 875  70  IVM  0 100 94.9 92.8  NA
4 50  4  ABA  0  
4 2600  208  ABA  0 100 98.4 97.7  100
4 225  18  ABA  0  
5 438  35  OX+PY
  0 
5 538  43  OX+PY  1 98.7 93.1 91.0  89
6 450  36  IVM  0  
6 275  22  IVM  0 100 93.9 91.4  100
7 1438  115  OX+PY  0 100 96.9 95.5  NA
7 0  0  OX+PY  0  
7 0  0  OX+PY  0  
a Farms 1-3 have over 30 horses, farms 4-7 have less than four horses. 
b Anthelmintics used: ABA = abamectin; MOX = moxidectin; OX+PY = Oxfendazole 
plus pyrantel; IVM = ivermectin. 
c NA indicates RESO LCL unable to be estimated because only one animal has a 
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Table 6. 
Comparison of precision and error rate for various methods of estimating efficacy 
under different conditions and detection sensitivities. Mean width of the confidence 
interval (CI) (precision) and mean error rate (percentage of results where the true 
efficacy was not enclose by the CI) for 10,000 Monte Carlo iterations of each 
scenario. In each scenario true efficacy was 95%. Method-1 was separate control and 
treated groups both counted post-treatment. Method-2 was pre- and post-treatment 
counts of the same animals. Method-3 required three additional counts pre- and post-
treatment at the prescribed detection level for two to five animals with the highest 
nematode egg counts. For RESO (Coles et al., 1992) the 95%CI was estimated, for 
Jeffreys interval (see text) the 95% and 99%CI were estimated. 
 
a k for NBD 0.5 
b Low Sensitivity 250/50 High Sensitivity 300/25
Method-  n animals  CI width % Error %  CI width %  Error % 
1 RESO 95
c  10/group 32 16.5 25  7.5
2 RESO 95  10 post/pre  29 13.5 21  2.2
2 Jeffreys 95
c  10 post/pre  14 5.7 9  6.6
3 Jeffreys 95  2 highest  10 5.4 7  5.8
3 Jeffreys 95  3 highest  9 5.5 6  6.0
3 Jeffreys 95  4 highest  9 5.8 5  6.0
3 Jeffreys 95  5 highest  8 6.1 5  6.0
2 Jeffreys 99
d  10 post/pre  19 1.5 12  1.5
3 Jeffreys 99  2 highest  14 1.4 9  1.4
3 Jeffreys 99  3 highest  12 1.3 8  1.4
3 Jeffreys 99  4 highest  11 1.4 7  1.5
3 Jeffreys 99  5 highest  11 1.5 7  1.4
   
a k for NBD 2.0   
1 RESO 95
c  10/group 22 12.5 14  4.0
2 RESO 95  10 post/pre  21 11.2 13  1.4
2 Jeffreys 95
c  10 post/pre  13 5.8 8  6.6
3 Jeffreys 95  2 highest  12 4.6 7  5.7
3 Jeffreys 95  3 highest  10 5.0 6  5.6
3 Jeffreys 95  4 highest  9 5.4 6  5.8
3 Jeffreys 95  5 highest  8 5.6 5  5.9
2 Jeffreys 99
d  10 post/pre  18 1.4 11  1.4
3 Jeffreys 99  2 highest  16 0.9 10  1.3
3 Jeffreys 99  3 highest  13 1.1 8  1.3
3 Jeffreys 99  4 highest  12 1.0 8  1.3
3 Jeffreys 99  5 highest  11 1.1 7  1.3
a k for the Negative Binomial distribution (NBD) was set at 0.5 or 2. 
b Assay sensitivity was either low by setting mean eggs/g faeces (epg) at 250 with a 
detection level of 50 or high by setting mean epg at 300 with a detection level of 25. 
c 95 indicates results shown are for 95%CI. 
d 99 indicates results shown are for 99%CI. 
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Figure 1.  1 
Estimated 95% and 99% lower confidence limits (LCL) for a FECRT based on: n the  2 
total number of eggs counted pre-treatment, x the total eggs observed post-treatment  3 
and efficacy of 100% (i.e. x=0). In Excel the 95%LCL was determined by the  4 
function: 95%LCL=100*(1-(BETAINV(0.975,x+1,n-x+1))), to estimate the 99%LCL  5 
0.995 replaces 0.975 in the inverse beta function (BETAINV) above. Note if less than  6 
a total of 30 eggs were observed pre-treatment then the efficacy estimate was  7 
unreliable as the LCL was below 90% and rapidly declines as n declines. Upper  8 
confidence limits (UCL) are 100% and not shown.  9 
  10 
Figure 2.  11 
Estimated 95% and 99% upper (UCL) and lower (LCL) confidence limits for a  12 
FECRT based on: n the total number of eggs counted pre-treatment, x the total eggs  13 
observed post-treatment for an efficacy of 90% (x=n/10) or 95%(x=n/20). In Excel  14 
the LCL was estimated as shown in Figure 1, the 95%UCL was determined by the  15 
function: 95%UCL=100*(1-(BETAINV(0.025,x+1,n-x+1))), to estimate the  16 
99%UCL 0.005 replaces 0.025 in the inverse beta function (BETAINV).  17 
  18 
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Figure 3.  1 
Distribution of 10,000 Monte Carlo efficacy results for three FECRT estimation  2 
methods. In this simulation: k=0.5 for the NBD, efficacy was 95%, ten animals per  3 
group, a high sensitivity FECRT with mean epg 300 and a detection factor of 25.  4 
Method-1 was separate control and treated groups counted post-treatment. Method-2  5 
was pre- and post-treatment counts from the same animals. Method-3 was pre- and  6 
post-treatment counts from the two animals with the highest counts, counted at a  7 
detection level of 6 epg. Note the bar at 81% efficacy includes all results equal to or  8 
less than 81%.  9 
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Figure 1. 
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Figure 2. 
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Figure 3. 
 
 
Method-1: efficacy 95%, 300 epg, k=0.5, detection 25, 10/group.
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Method-2: efficacy 95%, 300 epg, k=0.5, detection 25, 10/group.
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Method-3: efficacy 95%, 300 epg, k=0.5, detection 6.
Highest 2 animals only.
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